» Articles » PMID: 7856051

The Pig As a Potential Xenograft Donor

Overview
Date 1994 Oct 1
PMID 7856051
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Miniature swine have several advantages over other potential donor species as a xenograft donor for clinical use. Among these advantages are: (1) unlimited availability; (2) size (similar to human beings); (3) breeding characteristics; (4) physiologic and immunologic similarities to humans. Because of the genetic disparity between these two species, routine immunosuppression will probably not suffice for the long-term survival of pig to primate xenografts. Studies are therefore underway to induce tolerance across this species barrier, utilizing a mixed chimerism approach which has previously been successful for allogeneic and concordant xenogeneic combinations. Hyperacute rejection has been eliminated by an absorption technique and pig kidney xenograft survivals up to 13 days have been achieved.

Citing Articles

Advances in experimental bladder models: bridging the gap between in vitro and in vivo approaches for investigating urinary tract infections.

Nissanka M, Dilhari A, Wijesinghe G, Weerasekera M BMC Urol. 2024; 24(1):206.

PMID: 39313789 PMC: 11418205. DOI: 10.1186/s12894-024-01590-w.


Pretransplant Screening for Prevention of Hyperacute Graft Loss in Pig-to-primate Kidney Xenotransplantation.

Hisadome Y, Eisenson D, Santillan M, Iwase H, Yamada K Transplantation. 2024; 108(8):1749-1759.

PMID: 39042769 PMC: 11287055. DOI: 10.1097/TP.0000000000004958.


Strategies of Bladder Reconstruction after Partial or Radical Cystectomy for Bladder Cancer.

Zeng X, Wu Y Mol Biotechnol. 2024; .

PMID: 38761327 DOI: 10.1007/s12033-024-01163-0.


Endotenon-Derived Type II Tendon Stem Cells Have Enhanced Proliferative and Tenogenic Potential.

Clerici M, Citro V, Byrne A, Dale T, Boccaccini A, Della Porta G Int J Mol Sci. 2023; 24(20).

PMID: 37894787 PMC: 10606148. DOI: 10.3390/ijms242015107.


Validation of airway porcine epithelial cells as an alternative to human in vitro preclinical studies.

Genna V, Adamo D, Galaverni G, Lepore F, Boraldi F, Quaglino D Sci Rep. 2023; 13(1):16290.

PMID: 37770485 PMC: 10539525. DOI: 10.1038/s41598-023-43284-7.